A critical advance in cancer investigation is arising with the use of VHH fragments to re-engage damaged p53. This crucial cancer inhibitor protein is frequently disabled in several types of tumors, resulting https://bookmarkmoz.com/story21960775/mini-antibodies-revive-tumor-suppressor-p53-a-new-pathway-for-tumor-therapy